Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 202,989 | 61,674 | 9,744 | 41,960 | 137,266 |
| Marketable Securities | 318,363 | 194,748 | 272,739 | 273,137 | 202,073 |
| Receivables | 911 | 72 | 316 | 170 | 1,035 |
| Other current assets | 0 | 21,500 | 23,849 | 23,849 | 23,849 |
| TOTAL | $532,400 | $288,947 | $313,799 | $342,310 | $368,987 |
| Non-Current Assets | |||||
| PPE Net | 21,227 | 795 | 684 | 732 | 1,080 |
| Intangibles | 97,900 | 97,900 | 97,900 | 97,900 | 97,900 |
| Other Non-Current Assets | 433 | 3,498 | 3,581 | 3,740 | 3,409 |
| TOTAL | $119,560 | $102,193 | $102,165 | $102,372 | $102,389 |
| Total Assets | $651,960 | $391,140 | $415,964 | $444,682 | $471,376 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,976 | 18,788 | 19,255 | 19,711 | 20,167 |
| Accounts payable and accrued liabilities | 19,725 | 16,355 | 11,291 | 12,142 | 13,064 |
| Accrued Expenses | 24,757 | 14,913 | 10,807 | 11,769 | 10,120 |
| TOTAL | $122,957 | $51,799 | $43,571 | $45,933 | $44,969 |
| Non-Current Liabilities | |||||
| Long Term Debt | 100,960 | 87,500 | 87,500 | 87,500 | 87,500 |
| Deferred Revenues | 76,499 | 1,743 | 2,218 | 2,311 | 1,618 |
| Other Non-Current Liabilities | 14,367 | 23,520 | 23,036 | 23,259 | 23,535 |
| TOTAL | $243,153 | $141,403 | $140,919 | $141,142 | $142,389 |
| Total Liabilities | $366,110 | $193,202 | $184,490 | $187,075 | $187,358 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 103,770 | 103,623 | 103,613 | 103,645 | 103,623 |
| Common Shares | 104 | 104 | 104 | 727 | 104 |
| Retained earnings | -1,108,934 | -1,195,684 | -1,160,402 | -1,132,328 | -1,104,252 |
| Other shareholders' equity | 34 | 311 | 351 | 276 | -453 |
| TOTAL | $285,850 | $197,938 | $231,474 | $257,607 | $284,018 |
| Total Liabilities And Equity | $651,960 | $391,140 | $415,964 | $444,682 | $471,376 |